New York City Comptroller Brad Lander is pressuring several major pharmaceutical retailers to dispense the abortion pill mifepristone or run the risk of divestment from the New York City pension fund.
“By failing to become certified mifepristone dispensers, these pharmacy giants put both women’s reproductive healthcare and investors’ money at risk,” Lander said in a press statement on Tuesday.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
